Browse 26479 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| January 7th, 2021 |
Effects of In Utero Alcohol Exposure on Adult Health and Disease (R01 - Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2021 |
Self-Management for Health in Chronic Conditions (R01 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2021 |
Self-Management for Health in Chronic Conditions (R15 Clinical Trial Not Allowed) |
National Institutes of Health |
| May 7th, 2021 |
Drug Repurposing for Conditions Affecting Neonates and Pregnant Women (R01 - Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2021 |
Community Partnerships to Advance Research (CPAR) (R15 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2021 |
Community Partnerships to Advance Research (CPAR) (R01 Clinical Trial Optional) |
National Institutes of Health |
| February 21st, 2020 |
Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R21 - Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2018 |
Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R01 Clinical Trial Optional) |
National Institutes of Health |
| March 28th, 2018 |
Health-professional Education Partnership Initiative (HEPI) (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 29th, 2018 |
Namibia DREAMS/Twagamenwa Activity |
South Africa USAID Pretoria |
| March 2nd, 2018 |
Tissue Mapping Centers for the Human BioMolecular Atlas Program (U54 Clinical Trials Not Allowed) |
National Institutes of Health |
| March 2nd, 2018 |
Transformative Technology Development for the Human BioMolecular Atlas Program (UG3/UH3 Clinical Trials Not Allowed) |
National Institutes of Health |
| May 7th, 2020 |
Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R01 ) |
National Institutes of Health |
| May 7th, 2020 |
Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R03 Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2020 |
Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R21 Clinical Trial Optional ) |
National Institutes of Health |
| January 7th, 2019 |
Personalized Strategies to Manage Symptoms of Chronic Illness (R15 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2019 |
Innovative Questions in Symptom Science and Genomics (R15 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2021 |
Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required) |
National Institutes of Health |
| January 7th, 2021 |
Self-Management for Health in Chronic Conditions (R21 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2021 |
Advancing Basic Neurobiology Toward Translation Through Assay Development (R01 Clinical Trials Not Allowed) |
National Institutes of Health |
|
| January 7th, 2021 |
Community Partnerships to Advance Research (CPAR) (R21 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2021 |
Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R15 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2021 |
Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R21 Clinical Trial Optional) |
National Institutes of Health |
| February 20th, 2018 |
Tribal Practices for Wellness In Indian Country |
Centers for Disease Control NCCDPHP |
| March 1st, 2018 |
Administrative Supplements to NCI Grant and Cooperative Agreement Awards to Support Collaborations with the PDX Development and Trial Centers Research Network (PDXNet)(Admin Suppl - Clinical Trial Not Allowed) |
National Institutes of Health |
| March 19th, 2018 |
Discovery and Biological Signatures of Diet Derived Microbial Metabolites (R01 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2021 |
NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00-Clinical Trial Required) |
National Institutes of Health |
| January 5th, 2021 |
BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR)(R43/R44 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2021 |
Human Subjects Mechanistic and Minimal Risk Studies (R21 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2021 |
NIBIB Exploratory/Developmental Research Grant Program (R21) (Clinical Trial Optional) |
National Institutes of Health |
| March 26th, 2018 |
Pragmatic Trials of Managing Multimorbidity in Alzheimers Disease (R01 Clinical Trial Required) |
National Institutes of Health |
| September 7th, 2020 |
Synthetic Biology for Engineering Applications (R01) (Clinical Trial Optional) |
National Institutes of Health |
| March 26th, 2018 |
Interdisciplinary Research to Understand the Complex Biology of Resilience to Alzheimers Disease Risk (R01 - Clinical Trial Not Allowed) |
National Institutes of Health |
| March 28th, 2018 |
From Association to Function in the Alzheimers Disease Post-Genomics Era (R01 - Clinical Trial Not Allowed) |
National Institutes of Health |
| July 15th, 2019 |
BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 - Clinical Trials Not Allowed) |
National Institutes of Health |
| March 30th, 2018 |
Non-Invasive Diagnostics to Improve Gynecologic Health (R43/R44 - Clinical Trial Optional) |
National Institutes of Health |
| October 6th, 2020 |
BRAIN Initiative: Biology and Biophysics of Neural Stimulation (R01 - Clinical Trials Optional) |
National Institutes of Health |
| May 7th, 2020 |
Advancing the Science of Geriatric Palliative Care (R01 - Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2020 |
Advancing the Science of Geriatric Palliative Care (R21 - Clinical Trial Optional) |
National Institutes of Health |
| July 24th, 2020 |
Device-Based Treatments for Substance Use Disorders (UG3/UH3) (Clinical Trial Optional) |
National Institutes of Health |
